(Barron's) JPMorgan: 5 Investment Tips for 2014

JPMorgan: 5 Investment Tips for 2014

JPMorgan's David Kelly has drafted a five-point list. Among his resolutions: "income is more important than yield." r Entering 2014, the global investment environment is as challenging as ever. After a super 2013 in returns, U.S. equities can no longer be considered inexpensive and yet still look attractive relative to the prospective returns on savings accounts and long-term bonds. Long-term bond yields are higher than a year ago but could still rise further as the Federal Reserve begins to reduce quantitative easing.

While many international stocks appear more attractive than their U.S. counterparts, both developed nations and emerging markets face challenges in returning to a path of steady growth in economic output and earnings.

However, amidst all this uncertainty, investors should remember that a great deal of their personal investment performance depends not on the behavior of markets but rather on the discipline with which they approach investing.

With this in mind, here are five investment resolutions to consider for 2014:

REMEMBER TO REBALANCE: As part of any long-term plan, investors should have a strategic asset allocation, divvying up their portfolio into domestic stocks, international stocks, fixed income, alternatives, cash, etc. Sometimes, because one asset class appears particularly cheap or expensive, it makes sense to deviate from this allocation. However, very often the movement of markets themselves will alter this allocation. As a simple example, a portfolio that was composed of 50% stocks and 50% bonds at the start of 2012 (as represented by the S&P 500 and the Barclay's Aggregate respectively) would now be 59% stocks and 41% bonds. While there is still a case for an overweight to stocks relative to a normal portfolio, a reasonable question to ask is whether this shift in asset allocation is justified by a different view of the world from two years ago and, if not, whether the portfolio should be rebalanced back to its original allocation provided this can be achieved in a tax efficient manner.

INCOME IS MORE IMPORTANT THAN YIELD: In recent years, many investors have sought out high yielding bonds and stocks as a way to get a portfolio to supply a stream of income without having to sell any securities. The problem with this strategy is that the Federal Reserve has done its best to push down yields across the bond market and investors searching for yield have pushed up the prices of high-yielding equity securities eating into their long-term prospective returns. Moreover, there is no law in finance or logic that says an investor cannot sell principal. A more logical approach for 2014 may be to contemplate an appropriate income distribution from a portfolio and potentially achieve it through a systematic withdrawal from the portfolio. If that means selling growth stocks as they go up, so be it. It actually may be more tax efficient than trying to achieve this income from taking the coupon payment on a high-yield bond. In any event, investors should separate the issues of portfolio construction, which should be done solely from the perspective of risk and expected return, from the issue of how to generate an income from that portfolio, which can be achieved just as easily from capital gains as from dividends and interest payments.

AVOID BUYING HIGH AND SELLING LOW: Historical data clearly show that mutual fund investors pile in at the top of a market rally and get out at the bottom of a market crash. This inevitably leaves them with lower returns than if they had simply decided to buy and hold. But how do you avoid doing this? Knowing the current level of the University of Michigan's Index of Consumer Sentiment may help provide some guidance. Since 1970, this index has averaged a reading of 85.3, with six discernible peaks (averaging 99.9) and seven clear troughs (averaging 62.3). Over that period of time, if you had bought stocks at the peaks, the S&P 500 rose by just 1% over the following 12 months. On the other hand, if you had bought at the troughs, the S&P500 rose by an average of 22%.

As this is being written, the index is at 82.5, and is thus close to its mean. However, the next time people are very depressed will probably be a time to buy and the next time they are exuberant will likely be a time to sell.

REVIEW WHETHER YOU HAVE ENOUGH INVESTED OVERSEAS: At the end of the third quarter, international equities accounted for 52% of the global stock market. However, U.S. investors, across households and institutions, had just 18% of their equity money in non-U.S. investments. There are some legitimate reasons for having an outsized proportion of your portfolio in domestic issues. In particular, assuming that most of your expenses are denominated in dollars, having most of your assets in U.S. dollars avoids currency risk. Still, given the cyclical opportunities in a recovering Europe and the long-term opportunities in emerging markets, investors seem to have too much of a "home bias". 2014 should be a year in which to take a more global view.

DON'T IRRATIONALLY HIDE LONG-TERM MONEY IN SHORT-TERM INVESTMENTS: American investors have over $10 trillion sitting in "cash" accounts including savings accounts, money market mutual funds, time deposits and cash in Keogh and IRA accounts. Most of this money is not being used for day-to-day transactions but is being held as cash because cash is seen as being "safe" or because investors simply do not know what to do with it. This is almost certainly a mistake. Central banks, including the Federal Reserve, the European Central Bank and the Bank of Japan have all deliberately pushed the yield on cash accounts to close to zero in an attempt to stimulate economic growth but also to induce investors to take risks. Not surprisingly, balanced portfolios of stocks, bonds and alternatives routinely beat cash in terms of total return. While in any week there is no guarantee that balanced investing will beat cash, in the long-run it has done so with some consistency, particularly when cash yields are so low.

In summary, 2014 should be a year for thoughtful investing. It should be a year to consider rebalancing, to determine if you are invested for income rather than yield, to be confident you are investing based on logic rather than emotion and to think about more international investing. Most of all, it should be a year to verify that your long-term money is invested in long-term assets.

US After Hours

After Hours Summary: ORCL unchanged following earnings/guidance; AKS & SCS +7% on guidance; SMTC -18% on guidance

After Hours Gainers:

Companies trading higher in after hours in reaction to earnings: SCS +7%, AKS +7%, STAY +6%, PAYX +2%, ORCL unch, BGCP unch

Companies trading higher in after hours in reaction to news: ALIM +63% (co and FDA Enter Into Labeling Discussions for ILUVIEN, Agree Advisory Committee No Longer Necessary); PSDV +41% (co and FDA Enter Into Labeling Discussions for ILUVIEN, Agree Advisory Committee No Longer Necessary); HYGS +8% (selected as a participating partner in DOE project award to supply hydrogen fuel cell modules to the Center for Transportation and the Environment) USU +7% (was informed that Department of Energy Prepared to Extend American Centrifuge RD&D Program Three Months); TRLA +4% (S.A.C. Capital discloses 5.2% passive stake in 13G filing)

After Hours Losers:

Companies trading lower in after hours in reaction to earnings: SMTC -18%, APOG -2%, MLHR -1%

Companies trading lower in after hours in reaction to news: CVM -8% (co announces proposed public offering of common stock and warrants (amount not given)); GIG -8% (announces proposed public offering of common stock (no amount given))

US Close

Closing Market Summary: Stocks Notch Record Highs as Fed Trims Asset Purchases Equities settled on their highs after dovish forward guidance from the Federal Reserve offset the immediate impact of a tapering announcement. Although the Federal Open Market Committee reduced the size of its monthly asset purchases from $85 billion to $75 billion, it pledged to keep the target Fed Funds Rate near its current levels ‘well past the time that the unemployment rate declines below 6.5%.'

The dovish guidance was also the likely reason for Treasuries retracing all of their post-announcement losses. The benchmark 10-yr yield ended with a five basis point gain at 2.89%, which is essentially where it traded before the afternoon announcement.

During his press conference, Chairman Bernanke elaborated on the decision, saying the Committee plans to introduce further gradual reductions should economic data continue showing measurable improvement.

The S&P 500 surged 1.7%, wiping out its entire December loss. The index ended at a fresh record closing high as nine of ten sectors added at least 1.0%.

Heavily-weighted financials (+2.4%) and health care (+2.4%) finished in the lead. The health care sector received a considerable boost from biotechnology as the iShares Nasdaq Biotechnology ETF (IBB 219.31, +5.92) rose 2.8%.

Despite the relative strength of the two top-weighted sectors, the S&P 500 was kept from registering additional gains by the underperformance of technology (+0.8%). The sector lagged throughout the session as its top component, Apple (AAPL 550.77, -4.22), weighed. The largest tech stock fell 0.8% in the wake of Jabil Circuit's (JBL 15.67, -4.05) disappointing earnings report. Comments from China Mobile (CHL 52.61, +0.81) also weighed as the company said it is still working on an Apple iPhone deal after last week's reports implied the deal was nearing completion.

Today's broad gains overshadowed another key laggard, Ford (F 15.65, -1.05). The stock lost 6.3% after issuing fiscal-year 2014 guidance that fell short of expectations. Specifically, the company said it expects FY14 auto revenue to be about equal with FY13 (the current consensus calls for 11% growth) while adding its global auto operating margin target of 8-9% is at risk. The guidance update pressured rival General Motors (GM 41.27, -0.26) which slid 0.6%.

The removal of the uncertainty associated with today's FOMC decision caused the CBOE Volatility Index (VIX 13.80, -2.41) to slump to last week's levels.

Today's economic data focused on housing. The weekly MBA Mortgage Index fell 5.5% to follow last week's 1.0% increase.

November building permits rose to 1,007,000 from the prior month's upwardly revised rate of 1,039,000 (from 1,034,000). That was above the pace of 983,000 that had been expected among economists polled..

Regarding Housing Starts, September starts came in at 873,000 while the consensus expected a reading of 915,000. For October, Housing Starts were reported at 889,000 against the 920,000 expected by the consensus. Lastly, November starts increased to 1,091,000 while a reading of 950,000 was broadly anticipated.

Tomorrow, weekly initial claims will be reported at 8:30 ET while Existing Home Sales for November will be reported at 10:00 ET. In addition, November Leading Indicators and the December Philadelphia Fed Survey will also be released at 10:00 ET.

o Nasdaq +34.8% YTD o Russell 2000 +33.5% YTD o S&P 500 +27.0% YTD o DJIA +23.4% YTD

>>> Gogo shares lower by 11% following Delta (DAL) news that it will not allow v

Gogo shares lower by 11% following Delta (DAL) news that it will not allow voice calls in flight

Delta Air Lines CEO affirms no voice calls during flight for customers; (keeping GOGO on radar)

  • "Last week the U.S. Federal Communications Commission voted to seek public comment in consideration of lifting its ban on in-flight cell phone use. Delta will not allow cellular calls or internet-based voice communications onboard Delta or Delta Connection flights."
  • "Our customer research and direct feedback tell us that our frequent flyers believe voice calls in the cabin would be a disruption to the travel experience. In fact, a clear majority of customers who responded to a 2012 survey said they felt the ability to make voice calls onboard would detract from -- not enhance -- their experience."

>>> US Bank mergers and acquisitions: Many deals to come, but most will be small

Bank mergers and acquisitions: Many deals to come, but most will be small - Boenning & Scattergood

Boenning & Scattergood notes investment bankers and lawyers appear excited about a busier 2014 as more banks consider the potential sale of their institution. Because banks are sold and not bought, the pace of bank consolidation is largely determined by potential sellers' commitment to accept acquisition prices relative to trading values. They opine that the number of deals will increase from 2013's moderate pace but transactions will be smaller in size given fewer banks with the capacity or desire to buy larger institutions. Banks that appear to be near term acquirers: BMTC, WSBC, NYCB, PBCT... Cos with strong franchise values in our universe would readily attract buyers: AF, FCF.

>>> US Gapping down

Gapping down
‎
In reaction to disappointing earnings/guidance: JBL -17.6% (to divest aftermarket services for $725 million; downgraded to Sell from Neutral at Citigroup, downgraded at Needham), PAY -4%, GIS -2%, FDX -1.7%, ALB -0.4%, CFX -0.1%.

Other news: ONTX -17% (announces discontinuation of the Phase 3 ONTRAC study of intravenous rigosertib plus gemcitabine in front-line metastatic pancreatic cancer), TWGP -11.5% (announces sale of its 10.7% equity stake in Canopius Group ), OPXA -9.6% (prices 4.12 mln shares of common stock at $1.70 ), GOGO -5.6% (announces Ripplewood distribution and director resignations), WPCS -4.2% (announces acquisition of BTX Trader LLC, an early stage tech company engaged in developing a proprietary trading platform for bitcoins ), QCOR -3.9% (attributed to RTRX news), MWE -2.9% (has agreed to sell approximately 4,750,000 common units pursuant to a terms agreement under its equity distribution agreement with Citigroup), LNKD -1.8% (still checking), AAPL -1.3% (JBL related implications), GSK -1.1% (still checking), MU -1% (still checking), UPS -0.9% (following FDX results), SDRL -0.7% (still checking), OCRX -0.6% (Ocera Therapeutics and the Roche Group enter into technology transfer and license agreement), K -0.6% (following GIS results), TWO -0.4% (announces Q4 dividend of $0.26/share, down from prior $0.28/share), ETFC -0.3% (reports DARTs for November were 163,411, a 2% increase from October ).

Analyst comments: LSI -0.6% (downgraded to Equal-Weight from Overweight at Morgan Stanley), KGC -0.4% (ticking lower; downgraded to Neutral from Overweight at JP Morgan)

>>> US Gapping up

Gapping up
In reaction to strong earnings/guidance: HEI +5.7%, LEN +4.7%.

M&A news: SYNM +50.4%/ REGI +4.2% (Renewable Energy Group agrees to acquire Syntroleum; SYNM to receive 3,796,000 shares of REGI common stock). VCI +18.7% (Harland Clarke Holdings Corp. to acquire Valassis for $34.04 per share in cash).

A few European financial names showing strength: BCS +1.5%, RBS +1.3%, PUK +1.3% (light volume).


Select oil/gas related names showing strength: STO +1.3%, TOT +0.7%, PBR +0.7%, BP +0.4% (announces significant oil discovery at its Gila prospect in the deepwater US Gulf of Mexico).

A few solar names are trading higher: SPWR +2.2%, YGE +1.7%, JKS +1.5%, TSL +1.4%

Other news: ADEP +13% (announces preferred primary and secondary food packaging partnership with Harpak-ULMA), ARIA +12% (still checking), ADHD +8.9% (Alcobra Pharma: Metadoxine for the treatment of Fragile X Syndrome granted FDA orphan designation status), BCRX +8% (announced that it has selected two optimized plasma kallikrein inhibitors to advance into preclinical development as potential once-daily, oral treatments for the prevention of hereditary angioedema attacks), DAN +8% (continued strength; Dana Holding also lifts on Gabelli's reccomendation on CNBC), DHX +5% (announces new $50 mln stock repurchase program), OMER +4.8% (Omeros: Antibody inhibitor for the prevention of complement-mediated thrombotic microangiopathy receives FDA orphan designation status), CMO +4.2% (declares a $0.31 per share fourth quarter 2013 common dividend, unchanged from prior qtr), STXS +3.9% (continued strength), TWER +3.7% (continued momentum), BAK +3.2% (disclosed yesterday share sales agreement ), UBA +3% ( announces appointment of Stephan A. Rapaglia, Chief Opearting Officer), AMRS +2.7% (announces number of Sao Paulo city buses using Amyris Renewable Diesel has increased to 400 from 300; plans to produce its fragrance oil molecule from its own manufacturing facility in Brazil), NOK +2.7% (still checking; was mentioned positively on MadMoney), LPSN +2.7% (still checking), ARMH +1.9%/ ASML +1.6% (still checking), DEPO +1.4% (Nautilus Neurosciences announces the sale of CAMBIA to Depomed for up to $53.7 mln), RYAAY +1% (still checking), CNC +0.7% ( signs definitive agreement to purchase a majority stake in Fidelis SecureCare of Michigan), BBRY +0.6% (names John Sims President, Global Enterprise Services; Simms joins Blackberry in January from SAP (SAP), where he served as President of the Mobile Services business), PACD +0.4% (announces ultra-deepwater drillship Pacific Khamsin Begins Contract in Nigeria), BA +0.4% (following positive mention in Barrons), CHL +0.4% (China Mobile Chairman says company still in discussions with Apple (AAPL) regarding iPhone deal, according to reports),ABX +0.3% (announces resignation of Donald Carty and Robert Franklin from the Board of Directors, effective immediately).

Analyst comments: RRTS +2.4% (Roadrunner upgraded to Buy from Hold at Stifel), PAAS +1.4% (upgraded to Neutral from Underweight at JPMorgan), GRPN +1.2% (initiated with a Outperform at Northland Capital), SCCO +0.8% (upgraded to Buy from Neutral at Citigroup), URI +0.5% (United Rentals initiated with a Buy at Jefferies), INTC +0.2% (Intel added to the short-term buy list at Deutsche Bank)